Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Recent Advances in Pediatrics (Volume 18): Hot Topics
Suraj Gupte, Praveen C Sobti
PART ONE: SPOTLIGHT: HEMATOLOGY AND ONCOLOGY
CHAPTER 1:
Hematologic Manifestations of Systemic Disease
INTRODUCTION
MECHANISMS
RENAL DISEASE
COLLAGEN VASCULAR DISEASES AND THE ANEMIA OF CHRONIC DISORDERS
CARDIAC DISEASE
ENDOCRINE DISORDERS
METABOLIC DISEASES
NEUROLOGIC AND PSYCHIATRIC DISORDERS
PULMONARY DISEASE
GASTROINTESTINAL DISEASE
LIVER DISEASE
PANCREATIC DISEASE
SKIN DISEASES
INFECTIONS
SPECIFIC MANIFESTATIONS IN VARIOUS INFECTIONS
Malaria
Tuberculosis
Dengue
Infectious Mononucleosis
Parvovirus B19
Leptospirosis
Bordetella Pertussis
Leishmaniasis
Worm Infestations
Intrauterine Infections
Human Immunodeficiency Virus
CHAPTER 2:
Megaloblastic Anemia
INTRODUCTION
PHYSIOLOGIC AND BIOCHEMICAL CONSIDERATIONS
Folic Acid
Transport and Cellular Utilization
Cobalamin
Transport and Cellular Utilization
CLASSIFICATION OF MEGALOBLASTIC ANEMIA
Cobalamin Deficiency
Folic Acid Deficiency
Miscellaneous
Cobalamin Deficiency
Defective Release of Cobalamin from Food
Pernicious Anemia
Overgrowth of Intestinal Organisms
Ileal Abnormalities
Imerslund-Grasbeck Syndrome
Drug and Toxins
Transcobalamin-II Deficiency
Folate Deficiency
Malabsorption
Other causes of Megaloblastic Anemia
Clinical Features
Diagnosis (Table 2.1)
Treatment
CHAPTER 3:
Acute Leukemias
INTRODUCTION
ACUTE LYMPHOBLASTIC LEUKEMIA
Incidence
Epidemiology
Etiology
Pathogenesis
Clinical Presentation
DIFFERENTIAL DIAGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Diagnosis
Morphologic Classification of Leukemic Blasts
Immunophenotyping of Leukemic Blasts
Cytogenetics and Molecular Genetics of Childhood Acute Lymphoblastic Leukemia
Prognostic Factors
Management
Supportive Care
Specific Therapy
CNS Preventive Therapy
Consolidation and Intensification Therapy
Maintenance
Relapse
Late Effects
ACUTE MYELOGENOUS LEUKEMIA
Incidence
Etiologic Factors
Clinical Presentation
Patient Evaluation
Immunophenotyping
Cytogenetics
Prognosis
Treatment
Allogenic Bone Marrow Transplant
CHAPTER 4:
Component Therapy
INTRODUCTION
WHY NOT WHOLE BLOOD and WHY COMPONENTS?
PREPARATION OF BLOOD COMPONENTS
WHICH COMPONENTS?
STORAGE AND SHELF-LIFE
WHOLE BLOOD
STORAGE OF BLOOD
DISADVANTAGES OF WHOLE BLOOD
Complications
PACKED RED BLOOD CELLS (PRBC)
Special Considerations for Newborns
FROZEN BLOOD CELLS
LEUKOCYTE–POOR RBCs
PLATELET TRANSFUSIONS
TYPES OF PLATELETS
SPECIAL CONSIDERATIONS FOR NEWBORN
PLATELET TRANSFUSION EFFICACY
GRANULOCYTES
GUIDELINE FOR TRANSFUSION
SPECIAL CONSIDERATIONS FOR NEWBORNS
Dosage
CRYOPRECIPITATE
INDICATION FOR TRANSFUSION
FRESH FROZEN PLASMA
INDICATIONS FOR TRANSFUSION
SPECIAL CONSIDERATIONS FOR NEWBORNS
SPECIFIC FACTOR CONCENTRATES
LEUKODEPLETED BLOOD COMPONENTS
Methods of Leukodepletion
WBC Filter
Washed Cells
IRRADIATED BLOOD AND GVHD; TRANSFUSION
Gamma Irradiation
Indications
CHAPTER 5:
Stem Cells
INTRODUCTION
HEMATOPOIETIC
CONDITIONING THERAPY
CLASSES OF DISEASE TREATED
Direct Replacement of Diseased Blood/Marrow Cells
Red Cell and Platelet Disorders
Hemoglobinopathies
White Cell Disorders
Severe Combined Immune Deficiency (SCID)
Other Immunodeficiency Diseases
Bone marrow failure syndromes
Replacing Phagocytic Cells in Solid Organs
METABOLIC DISEASES
MUSCULAR DYSTROPHY
CARDIOVASCULAR
LIVER
NEUROLOGY
AUTOIMMUNE DISEASE AND ARTHRITIS
APPLICABILITY AND SAFETY OF SCT
INFECTIOUS COMPLICATIONS
GRAFT VERSUS HOST DISEASE
CHIMERISM
NEW DIRECTIONS
SUMMARY
CHAPTER 6:
Pediatric Bone Marrow Transplantation
INTRODUCTION
SOURCES OF STEM CELLS/DONORS
CORD BLOOD TRANSPLANTATION
Indications
Pre-transplant Conditioning Regimen
Outcome of BMT in Various Indications
Complications of Hematopoietic Stem Cell Transplantation
Acute Infections
Management of Central Venous Catheter (CVC) in Children
Calorie Requirement and Nutritional Support during BMT
LATE COMPLICATIONS OF TRANSPLANTATION
Chronic GVHD
Opportunistic Infections
Post-transplant Malignancies
Growth and Development Issues
Financial Issues
Obstacles in the Performance of Transplantation (e.g. Prohibitive Cost, Donor Availability)
Alternative Donor Program/Donor Registry
CHAPTER 7:
Oncologic Emergencies
INTRODUCTION
SUPERIOR VENA CAVA SYNDROME (SVCS) AND SUPERIOR MEDIASTINAL SYNDROME (SMS)
Clinical Features
Therapy
THE ALL-TRANS-RETINOIC ACID (ATRA) SYNDROME
Etiology and Pathophysiology
Differential Diagnosis
Therapy
HYPERLEUKOCYTOSIS
Pathogenesis
Evaluation
Therapy
TUMOR LYSIS SYNDROME (TLS)
Etiology and pathophysiology
Clinical Features and Investigations
Treatment
FEBRILE NEUTROPENIA
Definitions
Etiology
Evaluation of Fever with Neutropenia
Evaluation of Afebrile Neutropenia with Localizing Signs
Risk Assessment in Febrile Neutropenia
High-risk
Low-risk
Evaluation of Febrile Nonneutropenia
Empirical Antibiotic Therapy in Febrile Neutropenia
Antibiotic Monotherapy
Two Drug Therapy without a Glycopeptide Antibiotic (Vancomycin)
Therapy with Glycopeptide (Vancomycin) Plus 1–2 Drugs
Management with Antibiotics During First Week of Therapy
Patient Afebrile within 3–5 days of Treatment
Persistent Fever after 3–5 days of Treatment
Duration of Antimicrobial Therapy
Antifungal Agents
Amphotericin B
Lipid Formulations of Amphotericin B
Antifungal Imidazoles and Triazoles
Fluconazole
Itraconazole
Voriconazole
Antiviral Drugs
Colony Stimulating Factors
PART TWO: GENERAL / MISCELLANEOUS
CHAPTER 8:
Fluid Therapy in Acute Illnesses
INTRODUCTION
MAINTENANCE FLUIDS
MAINTENANCE WATER
MAINTENANCE ELECTROLYTES
REPLACEMENT FLUID THERAPY5
GI Losses
Urine Output
Losses from Surgical Drains and Third Space
DEFICIT FLUID THERAPY
Hyponatremic Dehydration
Hypernatremic Dehydration
FLUID THERAPY IN SPECIAL SITUATIONS
Shock
Dengue Hemorrhagic Fever and Dengue Shock Syndrome
Burns
Perioperative Fluids
SIADH
Diabetic Ketoacidosis
CONCLUSION
CHAPTER 9:
Cystic Fibrosis Revisited
INTRODUCTION
EPIDEMIOLOGY
ETIOPATHOGENESIS
Genetics
Pathophysiology
Pathology
CLINICAL MANIFESTATIONS
Causes of malnutrition in CF include:
DIAGNOSIS11
Newborn Screening
Prenatal Diagnosis
TREATMENT
Specific Replacement Therapy12,13
Remaining Nutritional Therapy14–16
Enhanced Needs
Diet
Special Diets
Diet in Comorbidities
Supplementation with Vitamins and Micronutrients
Fluids and Electrolytes
Therapy Targeted at Respiratory System
Inhalation Therapy
Airway Clearance Therapy
Endoscopy and Lavage
Antibiotic Therapy17
Mucolytics
Bronchodilator Therapy
Anti-inflammatory Therapy
Immunization
Other Therapies
Growth Hormone
Dehydration, Dyselectrolytemia and Salt Depletion
Rhinosinusitis
Nasal Polyps
Surgical Intervention
COMPLICATIONS AND THEIR TREATMENT
PROGNOSIS18–20
CHAPTER 10:
Pediatric Malaria
INTRODUCTION
LIFE CYCLE
CLINICAL DISEASE
Uncomplicated Malaria
Severe Malaria
Clinical Manifestation
Laboratory Test
DIAGNOSIS OF MALARIA
Clinical Diagnosis
Parasitological Diagnosis
The Choice Between RDTs and Microscopy
RECOMMENDATIONS ON MALARIA DIAGNOSIS AND TREATMENT2
Antimalaria Drugs3
Monitoring of Antimalarial Drug Resistance
In Vivo Tests
Drug Resistance in Plasmodium Falciparum2
Plasmodium vivax Resistance
Prevention of Resistance by use of Combination Therapy
Goals of Therapy3
Recent Trends in Treatment of Malaria
Uncomplicated Malaria
Severe Malaria
Treatment of Uncomplicated P. falciparum Malaria
Antimalarial Combination Therapy
Definition
Artemisinin-based Combination Therapy (ACT)
Challenges in Implementing ACT
Non-artemisinin Based Combination Therapy
ACT—options
Dosing Schedule for Artemether-lumefantrine (Co-artemether)
Artesunate + sulfadoxine–pyrimethamine
Artesunate + mefloquine
Irrational Treatment Strategies
Additional Aspects of Clinical Management
Treatment Failures
Recommended Second-line Antimalarial Treatments
SPECIAL ISSUES
Infants
Treatment of Severe Falciparum Malaria
WHO Recommendations2
Adjustment of Dosing in Renal Failure or Hepatic Dysfunction
Follow-on Treatment
TREATMENT OF UNCOMPLICATED VIVAX MALARIA
Blood Stage Infection
Chloroquine-resistant Vivax Malaria
Liver Stage Infection
Monitoring Therapeutic Efficacy for Vivax Malaria
Mixed Malaria Infections
Reversal of Transmission Advantage by Artemisinins
FUTURE
CHAPTER 11:
Cerebral Malaria
INTRODUCTION
CLINICAL FEATURES
PATHOPHYSIOLOGY
PATHOLOGY
IMMUNOLOGY
DIAGNOSIS
MANAGEMENT OF CEREBRAL MALARIA
Immediate Management
Antimalarial Chemotherapy
Artemisinin Derivatives
Quinine
The role of corticosteroids and osmotic agents
Corticosteroids
Osmotic Agents
Supportive Therapy
Antibiotics
Anticonvulsants
Blood Transfusion
Exchange Transfusion
Fluids
Inotropic Support
Hypoglycemia
Raised Intracranial Pressure
Ventilation
POST-MALARIA NEUROLOGICAL SYNDROMES
DRUG RESISTANCE
OUTCOME
NEWER STRATEGIES
Desferrioxamine
N-acetyl Cysteine
Pentoxifylline
Vasoactive Intestinal Polypeptide (VIP)
Anti-TNF-α monoclonal Antibody
Anti-apoptosis Agents
Bacillus Thuringiensis Crystal Protein
Drugs with Doubtful or Harmful Effect
CHAPTER 12:
Chikungunya Fever—A Re-emerging Viral Disease
INTRODUCTION
CAUSATIVE AGENT
Virus classification
Vector
Mode of Transmission
Reservoir of infection
EPIDEMIOLOGY
RE-EMERGENCE OF CHIKUNGUNYA INFECTION
Outside India
In India
PATHOGENESIS
CLINICAL FEATURES2
DIFFERENTIAL DIAGNOSIS
DIAGNOSIS
Clinical
Laboratory Diagnosis10
Serological Tests
Molecular Diagnosis
MANAGEMENT
PROGNOSIS
PREVENTION
Control of Mosquito Breeding
Protection from Mosquito Bites
Vaccine against Chikungunya
Surveillance
CHAPTER 13:
H. pylori Infection: Noninvasive Tests
INTRODUCTION
ACTIVE TESTS
Urea breath test
Stool Tests
Fecal Detection of H. pylori DNA by Polymerase Chain Reaction (PCR)
Fecal Detection of H. pylori Antigen
PASSIVE TESTS
Serology
Salivary Antibodies
Urine Antibodies
CHAPTER 14:
Acute Asthma: Trends in Management
WHY IS ACUTE ASTHMA IMPORTANT?
DEFINITIONS
MANAGEMENT OF ACUTE ASTHMA
ASSESSMENT OF SEVERITY
Initial Rapid Assessment of Severity
RISK FACTORS FOR DEATH FROM ASTHMA6
SPECIAL CONSIDERATIONS IN THE ASSESSMENT AND TREATMENT OF INFANTS6
DETAILED CLINICAL ASSESSMENT6,9,10
History
Physical Examination
Objective Functional Assessment
Laboratory Studies
INITIAL TREATMENT
PRINCIPLES OF THERAPY9,10
Management at Home1,6,15
Management at Hospital1,5,6,9,10,15
Oxygen
Inhaled Short Acting Beta 2 Agonists
Anticholinergics
Corticosteroids
ASSESSMENT OF RESPONSE TO INITIAL THERAPY9,10,15
Good Response
Partial Response
Poor Response
FURTHER MODIFICATION OR ADDITION OF TREATMENT9,10,15
Continue Initial Therapies
Fluids and Electrolytes
Frequent Assessments and Monitoring
Addition of Other Drugs
Intravenous Methylxanthines
Intravenous Magnesium Sulphate
Heliox9,10,15
Intravenous beta-2 Agonists9,10
Intensive Care Management6,9,10,15
Transfer to PICU
Monitoring
Continuation of Therapy
Intubation and Mechanical Ventilation
Other Modalities9,10
Recovery Phase and Discharge
When to discharge?
What should be prescribed on discharge?
Patient education and follow-up advice6
CHAPTER 15:
Severe Respiratory Distress
INTRODUCTION
PEDIATRIC CONSIDERATIONS
PATHOPHYSIOLOGY
EVALUATION OF A CHILD WITH RESPIRATORY DISTRESS
Physical Examination2–7
Respiratory Rate
Respiratory Rhythm
Retraction
Intercostal Bulging
Auscultatory Signs
Grunting
Flaring of Alae Nasi
Paradoxical Breathing
Pulses Paradoxus
Cyanosis
Cardiovascular Signs
Neurological Signs
LABORATORY STUDIES2–5
Hematological Tests
Imaging Studies
Arterial Blood Gases
Other Tests
Pulmonary Function Tests
MANAGEMENT
Extrathoracic Airway Support
Endotracheal Intubation
Lung and Respiratory Pump Support
Mechanical Ventilation2,4,5,9
Adjuvant Therapies for Severe Hypoxemia
Prone Position
Inhaled Nitric Oxide (NO)
Administration of Exogenous Surfactant
Extracorporeal Life Support (ECLS)9
Medication
PROGNOSIS
FURTHER OUTPATIENT CARE
CHAPTER 16:
Hospital-acquired Pneumonia
INTRODUCTION
EARLY VS LATE ONSET
PATHOGENESIS
ETIOLOGY
CLINICAL FEATURES
DIAGNOSIS
Laboratory Studies
Imaging Studies
BRONCHOSCOPIC TECHNIQUES
Lung Tissue (culture and histology)
OTHERS
DIFFERENTIAL DIAGNOSIS
TREATMENT
Supportive Care
PREVENTION
PROGNOSIS
CHAPTER 17:
Oxygen Therapy
INTRODUCTION
NATURE OF OXYGEN
OXYGEN AND ENERGY
OXYGEN CASCADE
OXYGEN THERAPY
OXYGEN TRANSPORT
a. Whole Blood Oxygen Content
Oxygen Delivery
Oxygen Uptake
Oxygen Extraction Ratio
OXYHEMOGLOBIN DISSOCIATION CURVE
PULSE OXIMETER
SOURCES OF OXYGEN
Oxygen Cylinders
Oxygen Concentrators
Liquid Oxygen
OXYGEN ADMINISTRATION
LOW FLOW SYSTEM
Nasal Catheter
Nasal Prongs
Nasopharyngeal Catheter
Tracheostomy Oxygen Adapters
Simple Oxygen Masks
Partial-rebreathing Masks
Non-rebreathing Masks
HIGH-FLOW SYSTEM
An air-entrainment Mask or Venturi Mask
Air-entrainment Nebulizers
ENCLOSURE SYSTEMS
Oxygen Hoods
Closed Incubators
Oxygen Tent
INDICATION OF OXYGEN THERAPY33–35
Indication for Supplemental Oxygen Therapy
Potential Indications for Low Flow Oxygen Delivery Systems
Potential Indications for High Flow Oxygen Delivery Systems
OXYGEN TOXICITY
Atelectasis
Retinopathy of Prematurity
Pulmonary Oxygen Toxicity
WHEN TO STOP OXYGEN?
HYPERBARIC OXYGEN
HYPOXIA
Types of Hypoxia
Effects of Hypoxia
Respiration
Cardiovascular System
CNS
Cellular and Metabolic Effects
Treatment
HYPOXEMIA
Treatment
RECOMMENDATIONS FOR MONITORING OXYGEN THERAPY
CONCLUSION
CHAPTER 18:
Hot Water Epilepsy
INTRODUCTION
CLINICAL FEATURES
PATHOGENESIS
GENETICS OF HWE
INVESTIGATIONS
HWE
PROGNOSIS
CHAPTER 19:
Intractable Pediatric Epilepsy: Surgical Aspects
INTRODUCTION
EPILEPSY AND THE DEVELOPING BRAIN
THE EFFECTS OF ANTIEPILEPTIC DRUGS ON COGNITIVE FUNCTION
MEDICAL MANAGEMENT OF PEDIATRIC EPILEPSY
SURGICALLY REMEDIABLE PEDIATRIC EPILEPSY SYNDROMES AND THEIR SURGICAL TREATMENT33–35
HEMISPHERIC EPILEPSY
Outcome of Hemispheric Epilepsy Surgery
SUBHEMISPHERIC EPILEPSY
FOCAL EPILEPTIC DISORDERS
MULTIFOCAL EPILEPTIC DISORDERS
CHAPTER 20:
Perinatal Hypoxicischemic Encephalopathy
INTRODUCTION
NEURONAL PROPHYLAXIS
Gangliosides and Lazeroids
Hypothermia
Calcium and Neuronal Injury
Excitotoxic Neurotransmitter Antagonists
NMDA Receptor and Kainic Receptor Antagonists
Magnesium
Calcium Channel Antagonists
Free Radical Scavengers
Free Radical Scavengers and Synthesis Inhibition and Related Approaches
Neuronal Rescue
Immune Modulation
Anticonvulsants
Neurotrophins
Apoptosis Inhibition
CHAPTER 21:
Care of Extremely Low Birth Weight Infants
INTRODUCTION
MANAGEMENT OF ELBW BABIES
Antenatal Management
Delivery Room Management
Additional Trained Personnel
Additional means of Maintaining Temperature
Oxygen Blender and a Pulse Oximeter
Consider giving CPAP
Management in NICU
Surfactant Replacement Therapy
Respiratory Support
Fluids and Electrolytes
Cardiovascular Support
Control of Infection
Nutrition
MANAGEMENT OF COMPLICATIONS
Hyperbilirubinemia
Necrotizing Enterocolitis
Intraventricular Hemorrhage
Periventricular Leukomalacia
Apnea of Prematurity
Anemia
Immunization of ELBW Infants
Emotional Support to Parents
Follow-up Care
Vision
Hearing
CHAPTER 22:
Noninvasive Ventilation in the Newborn
INTRODUCTION
POSITIVE PRESSURE VENTILATION
Mechanism of Action
Indications
Contraindications
Flow Generation
Airway Interface
Positive Pressure System
Practical Considerations
NASAL INTERMITTENT POSITIVE PRESSURE VENTILATION (NIPPV)
Vapotherm
NEGATIVE PRESSURE VENTILATION
CHAPTER 23:
Chemoprophylaxis in Pediatric Practice
INTRODUCTION
GENERAL PRINCIPLES OF CHEMOPROPHYLAXIS
CHEMOPROPHYLAXIS IN CHILDREN WITH CONDITIONS PREDISPOSING TO INFECTIONS
Prevention of Recurrence of Rheumatic Fever
Duration
Prophylaxis in Children with Cardiac Abnormalities
Drugs and Dosage
Urinary Tract Infection9
Chemoprophylaxis in Children with Asplenia
Indications
Chemoprophylaxis in Children with Recurrent Otitis Media (Table 23.4)
Other Underlying Conditions
Chemoprophylaxis in Healthy Children
SPECIFIC PATHOGENS
Neisseria Meningitis (Meningococcal Meningitis)
B or Detella Pertussis
Corynebacterium Diphtheriae
Cholera
Chemoprophylaxis for Malaria (Table 23.5)
Chemoprophylaxis for Tuberculosis
Chemoprophylaxis for Hemophilus Influenza B
Simplex Chemoprophylaxis for Herpes
Chemoprophylaxis for Scabies
CHEMOPROPHYLAXIS FOR PREVENTION OF FETAL INFECTIONS
Early Onset Group B Streptococcal Infection (GBS)
Prevention of Vertical Transmission of HIV Infection to the Fetus
CHEMOPROPHYLAXIS FOR NEONATAL INFECTIONS
CHEMOPROPHYLAXIS FOR SURGICAL PROCEDURES AND TRAUMA
Principles1
CHEMOPROPHYLAXIS FOR PREVENTION OF HIV INFECTION
Primary Prevention of Mother to Child transmission27–29,36,37
Prevention of Pneumocystis Carnii Pneumonia in HIV Infected Children29–32
Indications
Herpes Simplex27,31
Varicella Zoster Virus27,31
Cytomegalovirus27,31
PROPHYLAXIS FOR NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS31
PROPHYLAXIS FOR TOXOPLASMOSIS31
PROPHYLAXIS FOR FUNGAL INFECTIONS31
Cryptococcal Infections
Candida Infections
CHEMOPROPHYLAXIS WITH RECURRENT BACTERIAL INFECTIONS31
POST-EXPOSURE PROPHYLAXIS29–35
CHAPTER 24:
Immunosuppressive Therapy
INTRODUCTION
MANIPULATIONS OF IMMUNE RESPONSE
CLASSIFICATION OF IMMUNOSUPPRESSIVE DRUGS
MECHANISM OF ACTION
GLUCOCORTICOIDS
CYCLOPHOSPHAMIDE
METHOTREXATE
AZATHIOPRINE AND MERCAPTOPURINE
CYCLOSPORINE
TACROLIMUS
SIROLIMUS (SRL)
MYCOPHENOLATE
LEFLUNOMIDE AND MALONONITRILOAMIDES
ACTINOMYCIN-D
ANTIBODIES
Anti-lymphocyte (ALG) and Anti-thymocyte globulins (ATG)
Intravenous Immunoglobulin
Daclizumab and basiliximab
T-cell receptor directed antibodies
HYDROXYCHLOROQUINE
SMALL BIOLOGICAL AGENTS
CHAPTER 25:
Hypertensive Emergencies
INTRODUCTION
WHAT IS HYPERTENSION?
What is hypertensive urgency4–7 and what is an emergency?4–7
WHAT ARE THE CAUSES?
WHAT ARE THE CLINICAL PRESENTATIONS?
Asymptomatic or Mildly Symptomatic Hypertension
Accelerated Hypertension
Malignant Hypertension
Malignant Hypertensive Encephalopathy10
INVESTIGATIONS9,10
Tests to Establish the Cause
Tests for Evidences of Target Organ Injury
Tests for Associated Risk Factors
Tests to Establish the Cause
Tests for Target Organ Injury
Tests for Associated Risk Factors
MANAGEMENT10
Hypertensive Emergency
ABCs
Initial Management and Monitoring
Management of Life-threatening Complications
Emergency Antihypertensive Therapy
Poststabilization Care
HYPERTENSIVE URGENCY10
PROGNOSIS
CHAPTER 26:
Hygiene Hypothesis and its Relevance
INTRODUCTION
HYGIENE HYPOTHESIS
IMMUNOLOGICAL BASIS OF HYGIENE HYPOTHESIS
EVIDENCE IN FAVOR OF HYGIENE HYPOTHESIS
Proxy Measures of Microbial Exposure
Direct Measures of microbial exposure
Food-borne and Gastrointestinal Infections
Respiratory Infections
Malaria
Nonspecific Effects of Infection and the Total Burden of Infection
Factors Influencing the Body's Response to Infection
Non-microbial Factors and Risk of Developing Atopy
Autoimmune Diseases and Other Diseases of Immune System Dysregulation
THE FUTURE
Need for an Extension of the Hygiene Hypothesis
Need for Renaming the Hygiene Hypothesis
Targeted Hygiene
Probiotics
The Next Generation Vaccines and Immunomodulatory Compounds
CHAPTER 27:
Scorpion Envenomation
INTRODUCTION
THE CULPRIT10
THE VENOM
EPIDEMIOLOGY
HISTORY
CLINICAL PRESENTATION
Neurological Predominance
Non-neurological Predominance
Neurotoxic Local Effects
Cytotoxic Local Effects
Central Nervous System Features
Autonomic Nervous System Features
Non-neurological Systemic Features
Respiratory
Gastrointestinal
Genitourinary
Hematological
Metabolic
LABORATORY INVESTIGATIONS
IMAGING STUDIES
PROGNOSIS
MANAGEMENT
CHAPTER 28:
Postgraduate Pediatric Education: A Reappraisal
INTRODUCTION
HISTORY OF MEDICAL EDUCATION IN INDIA
Curriculum Evaluations
POSTGRADUATE EDUCATION IN INDIA
IMPACT OF THE CURRENT POSTGRADUATE SELECTIONS
POSTGRADUATE CURRICULUM AND TRAINING—CURRENT STATUS AND SUGGESTIONS
CLINICAL TEACHING DURING THE POSTGRADUATE TRAINING
The One Minute Preceptor
MINI CLINICAL EXAMINATION (MINI-CEX)
POSTGRADUATE TRAINING AND UTILIZATION OF INFORMATION TECHNOLOGY
THE PLACE OF RESEARCH IN POSTGRADUATE TRAINING—‘THESIS/DISSERTATION’
TEACHING BY THE POSTGRADUATES
POSTGRADUATE EVALUATION—PRESENT AND FUTURE SUGGESTIONS
FACULTY DEVELOPMENT—TEACHING THE TEACHERS
APPENDIX 1
INDEX
TOC
Index
×
Chapter Notes
Save
Clear